Загрузка...
Lesson of the month 1: Septic arthritis with normal acute phase reactants and white cell count in a patient receiving tocilizumab
Septic arthritis represents 8–27% of cases of monoarthritis presenting to the emergency department. Tocilizumab is an interleukin-6 blocking monoclonal antibody with the mechanistic potential to interfere with the body's normal inflammatory response to an infectious insult. We present a case of...
Сохранить в:
| Опубликовано в: : | Clin Med (Lond) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Royal College of Physicians
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6297569/ https://ncbi.nlm.nih.gov/pubmed/28572233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.17-3-280 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|